Intermune Inc Revenue Growth Rates (ITMN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Intermune Inc  (ITMN)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ITMN's Revenue Growth by Quarter and Year

Intermune Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ITMN Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December -
3rd Quarter September -
2nd Quarter June 35.74
1st Quarter March 30.27
FY 66.01





ITMN Revenue second quarter 2014 Y/Y Growth Comment
Intermune Inc reported Revenue surge of 148.19% year on year in the second quarter 2014, to $ 35.74 millions, this is lower than Intermune Inc's recent average Revenue surge of 381.62%.

Looking into second quarter 2014 results within Healthcare Facilities industry 2 other companies have achieved higher Revenue growth. While Intermune Inc' s Revenue doubling of 148.19% ranks overall at the positon no. 238 in the second quarter 2014.


ITMN Revenue ( Y/Y Growth %) 2014
 2013 2012 2011
4th Quarter December - 212.53 % 209.02 % -98.9 %
3rd Quarter September - 161.89 % 3863.16 % -96.64 %
2nd Quarter June 148.19 % 159.93 % 316.54 % -77.42 %
1st Quarter March 187.46 % 115.78 % 275.38 % -78.62 %
FY   - 168.78 % 377.55 % -

Financial Statements
Intermune Inc's second quarter 2014 Revenue $ 35.74 millions ITMN's Income Statement
Intermune Inc's second quarter 2013 Revenue $ 14.40 millions Quarterly ITMN's Income Statement


ITMN Revenue (Quarter on Quarter Growth %)

 2014
 2013 2012 2011
4th Quarter December - 30.27 % 9.16 % 1300 %
3rd Quarter September - 36.94 % 35.92 % -85.71 %
2nd Quarter June 18.07 % 36.75 % 13.52 % 2.31 %
1st Quarter March 17.83 % 28.1 % 83.46 % -99.46 %
FY (Year on Year)   - 168.78 % 377.55 % -


Back to ITMN Growth rate Comparisons >> Back to ITMN Growth rate Comparisons >>


Revenue second quarter 2014 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #51
Overall #238

Revenue Y/Y Growth Statistics
High Average Low
3907.45 % 381.62 % -98.9 %
(Sep 30 2013)   (Dec 31 2013)
Revenue second quarter 2014 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #51
Overall #238
Revenue Y/Y Growth Statistics
High Average Low
3907.45 % 381.62 % -98.9 %
(Sep 30 2013)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Intermune Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
73.9 % 35.99 % 5.53 %
(Dec 31 2012)  


ITMN's II. Quarter Q/Q Revenue Comment
Intermune Inc achieved in the II. Quarter 2014 below company average Revenue jump of 18.07% quarter on quarter, to $ 35.74 millions.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Intermune Inc's Revenue growth quarter on quarter, overall rank is 951.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #139
Overall #951
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #139
Overall #951
Revenue Q/Q Growth Statistics
High Average Low
73.9 % 35.99 % 5.53 %
(Dec 31 2012)  


ITMN's II. Quarter Q/Q Revenue Comment
Intermune Inc achieved in the II. Quarter 2014 below company average Revenue jump of 18.07% quarter on quarter, to $ 35.74 millions.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Intermune Inc's Revenue growth quarter on quarter, overall rank is 951.


Intermune Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2014)		 12 Months Ending
(Mar 31 2014)		 12 Months Ending
(Dec 31 2013)		 12 Months Ending
(Sep 30 2013)		 12 Months Ending
(Jun 30 2013)
Cumulative Revenue 12 Months Ending $ 111.42 $ 90.08 $ 70.34 $ 52.87 $ 40.69
Y / Y Revenue Growth (TTM) 173.86 % 183.07 % 168.74 % 156.5 % 206.69 %
Year on Year Revenue Growth Overall Ranking # 128 # 154 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 23.69 % 28.07 % 33.04 % 29.95 % 27.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 478 # 242 # 0 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2014 period, Intermune Inc's cumulative twelve months Revenue were $ 111 millions, company would post below average annual Revenue growth of 27.85% year on year, if the fiscal year would end at Jun 30 2014.
A slow-down in the Intermune Inc's Revenue growth from the 30.27% growth in Mar 31 2014.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 128, from total ranking in previous quarter at 154.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 21
Overall # 128

Revenue TTM Y/Y Growth Statistics
High Average Low
182 %
 182 %
182 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 69
S&P 500 # 478
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2014 period, Intermune Inc's cumulative twelve months Revenue were $ 111 millions, company would post below average annual Revenue growth of 182% year on year, if the fiscal year would end at Jun 30 2014.
A slow-down in the Intermune Inc's Revenue growth from the 30.27% growth in Mar 31 2014.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 128, from total ranking in previous quarter at 154.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 21
Overall # 128

Revenue TTM Y/Y Growth Statistics
High Average Low
182 %
182 %
182 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 69
S&P 500 # 478




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ITMN's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2014 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2014
Wearable Health Solutions, Inc.255.88%$ 255.885 millions
Cytosorbents Corporation251.53%$ 251.532 millions
Livewire Ergogenics Inc.216.79%$ 216.794 millions
Lexicon Pharmaceuticals Inc 215.89%$ 215.888 millions
Corcept Therapeutics Inc209.41%$ 209.413 millions
Fresh Tracks Therapeutics Inc 209.41%$ 209.409 millions
Geron Corporation204.46%$ 204.464 millions
Insys Therapeutics, Inc.195.92%$ 195.925 millions
Noho, Inc.182.64%$ 182.637 millions
Pacira Biosciences inc 175.16%$ 175.159 millions
Momenta Pharmaceuticals inc 151.09%$ 151.089 millions
Intermune Inc148.19%$ 148.187 millions
Gi Dynamics Inc 142.77%$ 142.775 millions
Gilead Sciences Inc 136.14%$ 136.141 millions
Ontrak Inc 134.59%$ 134.586 millions
Novavax inc 133.90%$ 133.900 millions
Amarin Corp Plcuk129.20%$ 129.200 millions
Assertio Holdings inc 126.05%$ 126.052 millions
Soligenix inc 124.30%$ 124.300 millions
Intersect Ent Inc 117.61%$ 117.607 millions
Clearpoint Neuro Inc 111.36%$ 111.361 millions
Adynxx, Inc.107.85%$ 107.852 millions
Oncomed Pharmaceuticals Inc105.15%$ 105.150 millions
Adma Biologics Inc 101.85%$ 101.854 millions
Lannett Company Inc100.67%$ 100.675 millions
Palisade Bio Inc 100.00%$ 100.000 millions
Royalty Pharma Plc100.00%$ 100.000 millions
Prolung Inc 95.28%$ 95.277 millions
Adm Tronics Unlimited Inc 93.45%$ 93.447 millions
Cryoport inc 91.94%$ 91.938 millions


About Intermune Inc Revenue Growth Rates (ITMN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.